Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-17

FDA Approved: AMPHOTERICIN B — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original ANDA for Amphotericin B from Eugia US LLC, authorizing a generic Amphotericin B product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amphotericin B (Amphotericin B)

Snippet

ORIG AP for AMPHOTERICIN B (AMPHOTERICIN B)